Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood–brain barrier-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood–brain barrier

Published:2019-07-16 Issue:5 Volume:27 Page:933-940
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Zhou Li,Sun Xiaomin,Shi Yong,Liu Junpeng,Luan Guohui,Yang Yanwen

Funder

We thank the research fund from Weifang People's Hospital

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s10787-019-00611-7.pdf

Reference26 articles.

1. Bäck M (2007) The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Sci World J 7:1422–1439

2. Bäck M (2009) Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc Drugs Ther 23(1):41–48

3. Biber N, Toklu HZ, Solakoglu S, Gultomruk M, Hakan T, Berkman Z, Dulger FG (2009) Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury. Brain Inj 23(6):577–584

4. Camós S, Mallolas J (2010) Experimental models for assaying microvascular endothelial cell pathophysiology in stroke. Molecules 15(12):9104–9134

5. Colazzo F, Gelosa P, Tremoli E, Sironi L, Castiglioni L (2017) Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases. Mediat Inflamm 2017:2432958

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction;Scientific Reports;2024-02-09

2. Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia;Current Hypertension Reviews;2024-02

3. Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium;Pharmaceuticals;2024-01-18

4. Effect of montelukast/budesonide formoterol powder inhalation in chronic obstructive pulmonary disease;Tropical Journal of Pharmaceutical Research;2022-06-18

5. Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series;European Respiratory Journal;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3